Personalis is a pioneering company based in Fremont, California, dedicated to transforming cancer management through innovative personalized testing. By combining highly sensitive assays with proprietary algorithms, Personalis provides advanced insights into cancer evolution, enabling early detection of minimal residual disease and recurrence. Their products facilitate the selection of targeted therapies through ultra-comprehensive genomic profiling and enhance biomarker strategies for drug development. Committed to improving patient care, Personalis is focused on guiding cancer management from biopsy through the patient's journey.